This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0568U only for LucentAD™ Complete from Quanterix Corporation. This test analyzes a blood sample to detect key protein biomarkers that are associated with Alzheimer’s disease. It measures levels of beta amyloid (Aβ40 and Aβ42), their ratio, phosphorylated tau protein (such as pTau217), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) using an ultrasensitive molecular array. The result is reported as positive, intermediate, or negative for Alzheimer’s pathology.
For clinical responsibility, terminology, tips and additional info
start codify free trial.